Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure

Circulation Research

Volumn 84, Issue 6, 1999, Pages 735-740

  Meguro, Tomomi ^a   Hong, Chull ^a   Asai, Kuniya ^a   Takagi, Gen ^a   McKinsey, Timothy A ^b   Olson, Eric N ^b   Vatner, Stephen F ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Aortic banding; Ca2+; Calcineurin; Left ventricular hypertrophy

Indexed keywords

CALCINEURIN; CALCIUM ION; CYCLOSPORIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CHEMISTRY; BODY WEIGHT; CONTROLLED STUDY; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HEART WEIGHT; HEMODYNAMIC MONITORING; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0033515643     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.84.6.735     Document Type: Article

References (24)

1. Capasso JM, Palackal T. Olivetti G, Anversa P. Left ventricular failure induced by long-term hypertension in rats. Circ Res. 1990;66:1400-1412.
2. Desjardins S. Mueller RW, Cauchy MJ. A pressure overload model of congestive heart failure in rats. Cardiovasc Res. 1988;22:696-702.
3. Sadoshima J, Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol. 1997;59:551-571.
4. 1 receptor subtype. Circ Res. 1993;73:413-423.
5. + exchanger and cardiac hypertrophy. Circ Res. 1998;83:870-873.
6. Goto K, Warner TD. Molecular pharmacology. Endothelin versatility. Nature. 1995;375:539-540.
7. Kudej RK, Iwase M, Uechi M, Vatner DE, Oka N, Ishikawa Y, Shannon RP, Bishop SP, Vatner SF. Effects of chronic β-adrenergic receptor stimulation in mice. J Mol Cell Cardiol. 1997;29:2735-2746.
8. Iwase M, Bishop SP, Uechi M, Vatner DE, Shannon RP, Kudej RK, Wight DC, Wagner TE, Ishikawa Y, Homey CJ, Vatner SF. Adverse effects of chronic endogenous sympathetic drive induced by cardiac Gsα overexpression. Circ Res. 1996;78:517-524.
9. Cittadini A, Stromer H, Katz SE, Clark R, Moses AC, Morgan JP, Douglas PS. Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat: a combined in vivo and in vitro evaluation. Circulation. 1996;93:800-809.
10. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 1998;93:215-228.
11. Barinaga M. Signaling path may lead to better heart-failure therapies. Science. 1998;280:383.
12. Izumo S, Aoki H. Calcineurin: the missing link in cardiac hypertrophy. Nat Med. 1998;4:661-662.
13. Dorn GW II, Robbins J. Ball N. Walsh RA. Myosin heavy chain regulation and myocyte contractile depression after LV hypertrophy in aortic-banded mice. Am J Physiol. 1994;267:H400-H405.
14. Rockman HA, Wachhorst SP, Mao L, Ross J Jr. ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. Am J Physiol. 1994;266:H2468-H2475.
15. Hubbard MJ, Klee CB. Exogenous kinases and phosphatases as probes of intracellular modulation. In: Chad J, Wheal H. eds. Molecular Neurobiology: A Practical Approach. New York, NY: Oxford University Press; 1991:135-137.
16. Rusnak FR, Beressi AH, Haddy A, Tefferi A. Calcineurin protein phosphatase activity in peripheral blood lymphocytes. Bone Marrow Transplant. 1996;17:309-313.
17. Homcy CJ. Signaling hypertrophy: how many switches, how many wires. Circulation. 1998;97:1890-1892.
18. Harada K, Komuro I, Shiojima I, Hayashi D, Kudoh S, Mizuno T, Kijima K, Matsubara H, Sugaya T, Murakami K, Yazaki Y. Pressure overload induces cardiac hypertrophy in angiotensin II type IA receptor knockout mice. Circulation. 1998;97:1952-1959.
19. Sakata Y, Hoit BD, Liggett SB, Walsh RA, Dorn GW II. Decompensation of pressure-overload hypertrophy in Gαq-overexpressing mice. Circulation. 1998;97:1488-1495.
20. Pan J, Fukuda K, Kodama H, Makino S, Takahashi T, Sano M, Hon S, Ogawa S. Role of angiotensin II in activation of the JAK/STAT pathway induced by acute pressure overload in the rat heart. Circ Res. 1997;81: 611-617.
21. Sussman MA, Lim HW, Gude N, Taigen T, Olson EN, Robbins J, Colbert MC, Gualberto A, Wieczorek DF, Molkentin JD. Prevention of cardiac hypertrophy in mice by Calcineurin inhibition. Science. 1998;281: 1690-1693.
22. Hittinger L, Shannon RP, Bishop SP, Gelpi RJ, Vatner SF. Subendomyo-cardial exhaustion of blood flow reserve and increased fibrosis in conscious dogs with heart failure. Circ Res. 1989;65:971-980.
23. Luo Z, Shyu K-G, Gualberto A, Walsh K. Calcineurin inhibitors and cardiac hypertrophy. Nat Med. 1998;4:1092-1093.
24. Müller JG, Nemoto S, Laser M, Carabello BA, Menick DR. Calcineurin inhibition and cardiac hypertrophy. Science. 1998;282:1007a. Available at: http://www.sciencemag.org/cgi/content/full/282/5391/1007a.